Zwyer Alexander 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-13 4:02 pm Purchase |
2022-12-31 | 13G | NLS Pharmaceutics AG NLSP |
Zwyer Alexander | 31,350 3.900% |
1,350![]() (+4.50%) |
Filing |
2022-02-14 08:03 am Purchase |
2021-12-31 | 13G | NLS Pharmaceutics AG NLSP |
Zwyer Alexander | 30,000 7.400% |
30,000![]() (New Position) |
Filing |